Scintimammography with technetium-99m methoxyisobutylisonitrile: Comparison with mammography and magnetic resonance imaging

European Journal of Nuclear Medicine

Volumn 23, Issue 8, 1996, Pages 940-946

  Palmedo, H ^a   Grunwald F ^a   Bender, H ^a   Schomburg, A ^a   Mallmann, P ^a   Krebs, D ^a   Biersack, H J ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Breast cancer; Magnetic resonance imaging; Mammography; Scintimammography; Technetium 99m methoxyisobutylisonitrile

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; AGED; ARTICLE; BREAST BIOPSY; BREAST CANCER; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MAMMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; SCINTISCANNING; TIME; TUMOR VOLUME;

EID: 0029775096     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01084368     Document Type: Article

References (34)

1. Kelsey JL, Gammon MD. The epidemiology of breast cancer. Cancer 1991; 41: 146-165.
2. Andersson I. Mammographic screening and mortality from breast cancer: Malmö mammographic screening trial. Br J Med 1988; 297: 943-948.
3. Frisell J, Eklund G, Hellström L et al. Randomized study of mammography screening - preliminary report on mortality in the Stockholm trial. Breast Cancer Res Treat 1991; 18: 49-56.
4. Miller AB, Baines CJ, To T et al. Canada national breast screening study. Can Med Assoc J 1992; 147: 1459-1488.
5. Shapiro S, Venet W, Strax P et al. Current results of the breast cancer screening randomized trial: the health insurance plan of greater New York study. In: Day NE, Miller AB, eds. Screening for breast cancer. Toronto: Hans Huber: 1988; 3-15.
6. Ciatto S, Cataliotti L, Distante V. Nonpalpable lesions detected with mammography: review of 512 consecutive cases. Radiology 1987; 165: 99-102.
7. Hermann G, Janus C, Schwartz IS, Krivisky B, Bier S, Rabinowitz JG. Nonpalpable breast lesions: accuracy of prebiopsy mammographic diagnosis. Radiology 1987; 165: 323-226.
8. Robertson CL. A private breast imaging practise: medical audit of 25,788 screening and 1,077 diagnostic examinations. Radiology 1993; 187:75-79.
9. Kopans DB. Positive predictive value of mammography. AJR 1992; 158: 521-526.
10. Coveney EC, Geraghty JG, O'Laoide R, Hourihane JB, O'Higgins NJ. Reasons underlying negative mammography in patients with palpable breast cancer. Clin Radiol 1994; 49: 123-125.
11. Lannin DR, Harris RP, Swanson FH, Edwards MS, Swanson MS, Pories WJ. Difficulties in diagnosis of carcinoma of the breast in patients less than fifty years of age. Surg Gynecol Obstet 1993; 177: 123-126.
12. Joensuu H, Asola R, Holli K, Kumpulainen E, Nikkanen V, Parvinen LM. Delayed diagnosis and large size of breast cancer after a false negative mammogram. Eur J Cancer 1994; 30: 1299-1302.
13. Madjar H, Makowiec U, Mundinger A, Du Bois A, Kommoss F, Schillinger H. Value of high resolution sonography in breast cancer screening. Ultraschall Med 1994; 15: 20-23.
14. Kopans DB. What is a useful adjunct to mammography? Radiology 1986; 161: 560-561.
15. Harms SE, Flamig DP, Hesley KL, Meiches MD, Jensen RA, Evans WP, Savino DA, Wells RV. MR imaging of the breast with rotating delivery of excitation off resonance. clinical experience with pathological correlation. Radiology 1993; 187: 493-501.
16. Oellinger H, Heins S, Sander B et al. Gd-DTPA enhanced MRI of the breast: the most sensitive method for detecting multicentric carcinomas in female breast? Eur Radial 1993; 3: 223-226.
17. Orel SG, Schnall MD, Livolsi VA, Troupin RH. MR imaging with radiologic-pathologic correlation. Radiology 1994; 190: 484-493.
18. Heywang SH, Wolf A, Pruss E, Hubertz T, Eiermann W, Permanetter W. MR-imaging of the breast with Gd-DTPA: use and limitations. Radiology 1989; 171: 95-103.
19. Weinreb JC, Newstead G. Controversies in breast MRI. Magn Reson Q 1994; 10: 67-83.
20. Kaiser MA. MR-Mammographie. Radiologe 1993; 33: 292-299.
21. Kau CH, Wang SJ, Liu TJ. The use of technetium-99m methoxyisobutylisonitrile breast scintigraphy to evaluate palpable breast masses. Eur J Nucl Med 1994; 21: 432-436.
22. Khalkhali I, Mena I, Jouanne E et al. Prone scintimammography in patients with suspicion of breast cancer. J Am Coll Surg 1994; 178: 491-497.
23. Khalkhali I, Cutrone JA, Mena I. Scintimammography: the complementary role of Tc-99m sestamibi prone breast imaging for the diagnosis of breast carcinoma. Radiology 1995; 196: 421-426.
24. Khalkhali I, Cutrone JA, Mena I, Diggles L, Venegas R, Vargas H, Jackson B, Klein. Tc-99m sestamibi prone breast imaging for the diagnosis of breast carcinoma. J Nucl Med 1995; 36: 1784-1789.
25. Palmedo H, Schomburg A, Gruenwald F, Mallmann P, Krebs D, Biersack HJ. Scintimammography with Tc-99m MIBI in suspicious breast lesions. J Nucl Med 1996; 37: 626-630.
26. Taillefer R, Robidoux A, Lambert R, Turpin S, Laperrière J. Tc-99m sestamibi prone scintimammography to detect primary breast cancer and axillary lymph node involvement. J Nucl Med 1995; 36: 1758-1765.
27. Tiling R, Kress K, Pechmann M, Pfluger T, Knesewitsch P, Tatsch K, Hahn K. Integrated diagnosis of breast tumors: semiquantitative Tc-99m sestamibi imaging versus dynamic MRI [abstract] J Nucl Med 1994; 35: 51.
28. Waxman A, Nagaraj N, Ashok G, Khan S, Memsic L, Yadegar J, Silberman A, Jochelson M, Katz R, Phillips E. Sensitivity and specificity of Tc-99m MIBI in the evaluation of primary carcinoma of the breast: comparison of palpable and non-palpable lesions with mammography [abstract]. J Nucl Med 1994; 35: 78.
29. Nagaraj N, Waxman A, Ashok G, Khan S. Memsic L, Yadegar J, Phillips E. Comparison of SPECT and planar Tc-99m sestamibi imaging in patients with carcinoma of the breast [abstract]. J Nucl Med 1994; 35: 934.
30. Chiu ML, Kronauge JF, Piwnica-Worms D. Effect of mitochondrial and plasma membrane potentials on accumulation of hexakis 2-methoxyisobutylisonitrile technetinm in cultured mouse fibroblasts. J Nucl Med 1990; 31: 1646-1653.
31. Maublant JC, Zhang Z, Rapp M, Ollier M, Michelot J, Veyre A. In vitro uptake of technetium-99m teboroxime in carcinoma cell lines and normal cells: comparison with technetium-99m sestamibi and thallium-201. J Nucl Med 1993; 34: 1949-1952.
32. Khalkhali I, Cutrone JA, Mena I, Diggles L, Khalkhali S, Venegas R, Klein S. The usefulness of scintimammography (SMM) in patients with dense breasts on mammogram [abstract] J Nucl Med 1995; 36: 52.
33. Gilles R, Guenebretiere JM, Shapeero LG et al. Assessment of breast cancer recurrence with contrast-enhanced substruction MR-imaging: preliminary results in 26 patients. Radiology 1993; 188: 473-478.
34. Hilleren DJ, Anderson IT, Lindholm K, Linnell FS. Invasive lobular carcinoma: mammographic findings in a 10-year-experience. Radiology 1991; 178: 149-154.